QbD Product Portfolio consists of early stage and clinical ready assets ready for partnership/registration across Biotechnology/Plasma/Pharmaceuticals:
a. Biotech Products – Early Stage
Rituximab
Infliximab
Denosumab
GCSF
Peg-GCSF
b. Biotech Products – Late Stage
EPO
GCSF
Peg-GCSF
Monoclonal antibodies
Vaccines
c. CAR-NK cells
PDL-1
PSCA
CD19/CD22
d. Plasma & Critical Care Products
Remdesivir
Albumin
IVIG
Factor-VIII
Factor – IX
PCC
e. Export
Pharmaceuticals
Biotechnology
Medical Devices
Nutraceuticals